Welcome to my professional blog!
Biostatistician with over 6 years’ experience, I have developed my skills within an international environment in CRO (France) and mid/big pharmaceutical companies (France and USA).
Currently working as a Biostatistics Project Manager in a mid-pharma company, I am responsible of phase I to III clinical trials in Oncology and I provide statistical expertise and support in the development of new drugs.
As a Project Manager, I provide statistical expertise and leadership on the development of new drugs in Oncology therapeutic area. This role includes providing statistical leadership in the design, analysis, and interpretation of clinical studies at a compound/program level and promoting innovative design and analysis methodology.
As a Statistical Expert, I participate in international working groups focused on multiplicity issues and subgroup analysis in clinical trials. These groups aim at providing general information on:
Traditional and innovative approaches to the design and analysis of clinical trials with multiple objectives.
Exploratory and confirmatory subgroup analysis
What am I really passionate about? To provide statistical expertise for innovative clinical development plan and trial designs. Increasing drug development costs and failure rates require a more efficient drug development program with innovative designs and advanced analysis strategies, coupled together with more rigorous quantitative assessment of their ability to reliably answer key development questions.